Weight loss doctor appointments


OUR BIGGEST LOSER LOST 157 lbs*


W8MD corporate owned weight loss centers 

Poly-Tech Sleep & insurance Physician Weight Loss Center Philadelphia
1718, Welsh Rd, Philadelphia, PA, 19115

215-676-2334 

Our farthest patient for weight loss comes from Nassau, Bahamas! Testimonials!

Philadelphia weight loss doctor

King of Prussia Weight Loss

Poly-Tech Sleep & W8MD's King Of Prussia Weight Loss Center

987 Old Eagle School Rd, Ste 712, Wayne, PA, 19087 (King of Prussia)

215-676-2334 

Our farthest patient for help losing weight comes from Delaware! Testimonials


New York City Weight Loss

W8MD's NYC medical weight loss & Sleep Clinic at Sleep Medical Associates, PLLC

2003, Bath Avenue, Brooklyn, NY, 11214. 

Lear more about losing weight fast in NYC | Our weight loss doctor NYC

718-946-5500

Our farthest weight loss patient comes from Dallas, Texas! Testimonials

weight loss doctor new york city


W8MD Licensed locations 

West Hempstead, NY

 

The weight loss center in New Jersey Is closed as of May 2017.

BMI Calculator

Your Weight:
Your Height:

Weight loss tips


Saxenda for weight loss

On December, 23rd, 2014 the United States FDA approved Saxenda(liraglutide) 3mg, a powerful new injectable weight loss medication. At a lower dose of 1.2mg and 1.8mg, liraglutide(Victoza) has been FDA approved for treatment of diabetes and the medication has long been know to help people lose weight. The good news is that at a higher dose of 3mg, liraglutide has been shown to melt pounds faster and more efficiently than any of the other weight loss medications currently on the market. 

 Although physicians have been using Victoza off label for weight loss for a long time, Saxenda is specifically approved for weight loss and a person does not need to a diabetic to try this new medication. Approved for anybody with a body mass index of 30 or over with at least one weight related comobordity such as diabetes, high blood pressure, cholesterol problems, sleep apnea etc. 

The drug is also approved for adults with a BMI of 27 or greater (overweight) who have at least one weight-related condition such as hypertension, type 2 diabetes, or high cholesterol (dyslipidemia).

When approving this new weight loss medication Saxenda, 2nd in the year 2014 after Contrave, the FDA's acting deputy director, James Smith, MD said "obesity is a public health concern and threatens the overall well-being of patients,”

“Saxenda, used responsibly in combination with a healthy lifestyle that includes a reduced-calorie diet and exercise, provides an additional treatment option for chronic weight management.

Compared to its rival medications including the other new weight loss medications Contrave, Belviq and Qsymia, over 50% of patients who tried Saxenda lost 5% or more of their body almost twice as effective as the other weight loss medications.

New class of weight loss medications

Saxenda is a glucagon-like peptide-1 (GLP-1) receptor agonist and should not be used in combination with any other drug belonging to this class, including Victoza, a treatment for type 2 diabetes. Containg the same active ingreding liraglutide, Saxenda and Victoza contain the active ingredient (liraglutide) at different doses (3 mg and 1.8 mg, respectively).

Although the same ingredient as in the diabetes medication Victoza albeit at a higher dose, Saxenda is not indicated for the treatment of type 2 diabetes, as the safety and efficacy of Saxenda for the treatment of diabetes has not been established. 

Studies supporting use of Saxenda for weight loss

The safety and effectiveness of Saxenda were evaluated in three clinical trials that included approximately 4,800 obese and overweight patients with and without significant weight-related comborbid conditions. All patients received counseling regarding lifestyle modifications that consisted of a reduced-calorie diet and regular physical activity in addition to Saxenda.

Fabulous weight loss results

Results from a clinical trial that enrolled patients without diabetes showed that patients had an average weight loss of 4.5 percent from baseline compared to treatment with a placebo at one year.

In this trial, 62 percent of patients treated with Saxenda lost at least 5 percent of their body weight compared with 34 percent of patients treated with placebo. Results from another clinical trial that enrolled patients with type 2 diabetes showed that patients had an average weight loss of 3.7 percent from baseline compared to treatment with placebo at one year. In this trial, 49 percent of patients treated with Saxenda lost at least 5 percent of their body weight compared with 16 percent of patients treated with placebo.

 12 week trial of Saxenda for weight loss

Patients using Saxenda should be evaluated after 16 weeks to determine if the treatment is working. If a patient has not lost at least 4 percent of baseline body weight, Saxenda should be discontinued, as it is unlikely that the patient will achieve and sustain clinically meaningful weight loss with continued treatment.

Warnings and precautions

Saxenda has a boxed warning stating that tumors of the thyroid gland (thyroid C-cell tumors) have been observed in rodent studies with Saxenda but that it is unknown whether Saxenda causes thyroid C-cell tumors, including a type of thyroid cancer called medullary thyroid carcinoma (MTC), in humans. Saxenda should not be used in patients with a personal or family history of MTC or in patients with multiple endocrine neoplasia syndrome type 2 (a disease in which patients have tumors in more than one gland in their body, which predisposes them to MTC).

Side effects of Saxenda

Serious side effects reported in patients treated with Saxenda include pancreatitis, gallbladder disease, renal impairment, and suicidal thoughts. Saxenda can also raise heart rate and should be discontinued in patients who experience a sustained increase in resting heart rate.

In clinical trials, the most common side effects observed in patients treated with Saxenda were

  • nausea
  • diarrhea
  • constipation
  • vomiting
  • low blood sugar (hypoglycemia), and
  • decreased appetite.

Other related medications are also in the pipeline including once a week dosing type medications and are awaiting the FDA approval.

Liraglutide, with diet and exercise, maintained weight loss achieved by caloric restriction and induced further weight loss over 56 weeks. Improvements in some cardiovascular disease-risk factors were also observed. Liraglutide, prescribed as 3.0 mg per day, holds promise for improving the maintenance of lost weight.

Other similar weight loss medications

AstraZeneca's evenatide (Byetta, Bydureon), has also been found to aid weight loss although not yet approved directly for weight loss. Recently, the FDA approved albiglutide (Tanzeum), GlaxoSmithKline's GLP-1 contender, that is dose once a weeek injected subcutaneously.

Impressive weight loss results

When used along with diet and exercise, Liraglutide, maintained weight loss achieved by caloric restriction and induced further weight loss over 56 weeks in a research study which also showed improvements in some cardiovascular disease-risk factors were also observed. Liraglutide, prescribed as 3.0 mg per day, holds promise for improving the maintenance of lost weight.

Locations for physicians prescribing Saxenda and other weight loss medications


Pennsylvania
 Philadelphia Insurance Weight Loss & Sleep Center: 1718, Welsh Rd, Philadelphia, PA, 19115 Ph: 1-215-676-2334 

Philadelphia weight loss doctor

King Of Prussia Weight Loss & Sleep Center: 987 Old Eagle School Rd, Ste 712, Wayne, PA, 19087 Ph: 215-676-2334 


 New York

NYC Insurance Weight Loss & Sleep Center: 2003, Bath Avenue, Brooklyn, NY, 11214 Ph: 1-718-946-5500. 

weight loss doctor new york city


 

New Jersey

W8MD medical weight loss program at Vida Sleep Center of Dr. Felix Roque's office at 543, 45th Street, Union City, New Jersey. 543 45th St, Union City, NJ  07087Phone: (201) 766-6469. This center bills out of network for insurance.

Cities Served

Philadelphia weight loss centersPhiladelphiaKing Of PrussiaWarminster, Wayne, Norristown, Exton, West Chester, Lansdale, Pottstown, Bensalem, Norriton, Phoenixville, Collegeville, Ardmore, Drexel Hill, Springfield, Lansdale, Darby, Horsham, Willow Grove, Abington, Doylestown, Jenkintown etc.
New Jersey Weight Loss CentersUnion City, Jersey City, West New York
New York Weight Loss Centers Brooklyn, Staten Island, Manhattan, Long Island, West Hempstead, Franklin Square, NY, Hempstead, NY, Garden City, New Hyde Park, Uniondale, North Valley Stream,  New York City, Queens, Bronx, NYC, Bayonne
Counties Served: Philadelphia, Delaware, Chester, Bucks, Montgomery, Burlington, Kings, Richmond, Queens, Manhattan, Bronx, Nassau county NY, Hudson County, NJ

Physicians

Most physicians have nothing to offer their overweight patients other than simply say"Lose Weight!" or hand out a diet sheet.This is not useful for most patients as obesity needs a more thorough and structured approach! Physicians Be A W8MD Weight Loss Doctor

Before And After Weight Loss | Weight Loss Video Testimonials

Disclaimer

W8MD medical weight loss centers of America is designed to provide general information on our insurance physician weight loss program locations, and general weight loss information. W8MD medical weight loss website or any of our affiliated weight loss blogs is not intended to diagnose, treat, cure, or prevent any disease. Also note insurance coverage may vary based on your plan, deductibles, co-insurance etc. and our participation in your plan. Contact your insurance carrier for your coverage details. 

Individual results may vary. No expressed or implied warranties!

Bill of Rights and Health Disclaimer.

1(800)986-3007

(800-W8MD-007)

Think W'eight'MD for weight loss!